.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
QuintilesIMS
UBS
Baxter
Julphar
Express Scripts
Queensland Health
Dow
Cerilliant

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title: 1.alpha.-hydroxy vitamin D.sub.4 and novel intermediates and analogues
Abstract:Disclosed is 1.alpha.,24-dihydroxy vitamin D.sub.4 having the following structure: ##STR1## and pharmaceutical compositions containing said compound. The compound and composition are useful in the treatment of abnormal calcium metabolism. Also Disclosed is a method for the preparation of 1.alpha.,24-dihydroxy vitamin D.sub.4.
Inventor(s): Knutson; Joyce C. (Madison, WI), Bishop; Charles W. (Verona, WI), Moriarty; Robert M. (Oak Park, IL)
Assignee: Bone Care International, Inc. (Madison, WI)
Filing Date:Jun 24, 1994
Application Number:08/265,438
Claims:1. 1.alpha.,24 dihydroxy vitamin D.sub.4.

2. A pharmaceutical composition, comprising an amount effective to increase serum calcium in a patient suffering Vitamin D deficiency of 1.alpha.,24 dihydroxy vitamin D.sub.4 in combination with a pharmaceutically acceptable vehicle.

3. The pharamaceutical composition of claim 2, wherein said amount is administered orally.

4. 1.alpha.,24-dihydroxyvitamin D.sub.4 produced in accordance with the method comprising incubating 1.alpha.-hydroxyvitamin D.sub.4 with cultured human liver cells to form 1.alpha.,24-dihydroxyvitamin D.sub.4, and isolating and purifying the 1.alpha.,24-dihydroxyvitamin D.sub.4 via high pressure liquid chromatography.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Johnson and Johnson
Fuji
Chinese Patent Office
Deloitte
Farmers Insurance
Baxter
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot